Cargando…

Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donors

Ebola virus (EBOV) can cause severe hemorrhagic fever in humans, and no approved treatment is currently available. Although several antibodies have achieved good protection in animal models, the potential emerging isolates of ebolavirus and the unknown effects of experimental antibodies in humans un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Pengfei, Chi, Xiangyang, Liu, Guodong, Zhang, Guanying, Chen, Zhengshan, Liu, Yujiao, Fang, Ting, Li, Jianmin, Banadyga, Logan, He, Shihua, Yu, Changming, Qiu, Xiangguo, Chen, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153831/ https://www.ncbi.nlm.nih.gov/pubmed/32213108 http://dx.doi.org/10.1080/19420862.2020.1742457

Ejemplares similares

The Cytokine Response Profile of Ebola Virus Disease in a Large Cohort of Rhesus Macaques Treated With Monoclonal Antibodies
por: Banadyga, Logan, et al.
Publicado: (2019)

Potent neutralizing monoclonal antibodies against Ebola virus infection
por: Zhang, Qi, et al.
Publicado: (2016)

Virus inoculation and treatment regimens for evaluating anti-filovirus monoclonal antibody efficacy in vivo
por: Banadyga, Logan, et al.
Publicado: (2019)

Characterization of Two Neutralizing Antibodies against Rift Valley Fever Virus Gn Protein
por: Hao, Meng, et al.
Publicado: (2020)

The Roles of Ebola Virus Soluble Glycoprotein in Replication, Pathogenesis, and Countermeasure Development
por: Zhu, Wenjun, et al.
Publicado: (2019)

Atypical Ebola Virus Disease in a Nonhuman Primate following Monoclonal Antibody Treatment Is Associated with Glycoprotein Mutations within the Fusion Loop
por: Banadyga, Logan, et al.
Publicado: (2021)

Linked Mutations in the Ebola Virus Polymerase Are Associated with Organ Specific Phenotypes
por: Dong, Xiaofeng, et al.
Publicado: (2023)

AAV-monoclonal antibody expression protects mice from Ebola virus without impeding the endogenous antibody response to heterologous challenge
por: van Lieshout, Laura P., et al.
Publicado: (2022)

Developing Pseudovirus-Based Neutralization Assay against Omicron-Included SARS-CoV-2 Variants
por: Sun, Hancong, et al.
Publicado: (2022)

Purification and characterization of monoclonal IgG antibodies recognizing Ebola virus glycoprotein
por: Han, Baek-Sang, et al.
Publicado: (2018)

Ebola GP-Specific Monoclonal Antibodies Protect Mice and Guinea Pigs from Lethal Ebola Virus Infection
por: Qiu, Xiangguo, et al.
Publicado: (2012)

Identification of a clinical compound losmapimod that blocks Lassa virus entry
por: Zhang, Xiaoyu, et al.
Publicado: (2019)

Taï Forest Virus Does Not Cause Lethal Disease in Ferrets
por: Schiffman, Zachary, et al.
Publicado: (2021)

Molecular Characterization of the Monoclonal Antibodies Composing ZMAb: A Protective Cocktail Against Ebola Virus
por: Audet, Jonathan, et al.
Publicado: (2014)

Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variants
por: Chi, Xiangyang, et al.
Publicado: (2023)

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
por: Chi, Xiangyang, et al.
Publicado: (2020)

Conformation-Dependent High-Affinity Potent Ricin-Neutralizing Monoclonal Antibodies
por: Hu, Wei-Gang, et al.
Publicado: (2013)

Ebola virus VP24 interacts with NP to facilitate nucleocapsid assembly and genome packaging
por: Banadyga, Logan, et al.
Publicado: (2017)

Modeling Ebola Virus Transmission Using Ferrets
por: de La Vega, Marc-Antoine, et al.
Publicado: (2018)

Identification and characterization of a neutralizing monoclonal antibody that provides complete protection against Yersinia pestis
por: Liu, Weicen, et al.
Publicado: (2017)

Neutralization Epitopes in Trimer and Pentamer Complexes Recognized by Potent Cytomegalovirus-Neutralizing Human Monoclonal Antibodies
por: Ai, Yuanbao, et al.
Publicado: (2022)

A Monoclonal Antibody Produced in Glycoengineered Plants Potently Neutralizes Monkeypox Virus
por: Esqueda, Adrian, et al.
Publicado: (2023)

Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination
por: Chi, Xiangyang, et al.
Publicado: (2022)

A Murine Monoclonal Antibody With Potent Neutralization Ability Against Human Adenovirus 7
por: Wang, Rong, et al.
Publicado: (2019)

Assessing the contribution of interferon antagonism to the virulence of West African Ebola viruses
por: Dunham, Eric C., et al.
Publicado: (2015)

Protective Efficacy of Neutralizing Monoclonal Antibodies in a Nonhuman Primate Model of Ebola Hemorrhagic Fever
por: Marzi, Andrea, et al.
Publicado: (2012)

Peste des Petits Ruminants Virus-Like Particles Induce a Potent Humoral and Cellular Immune Response in Goats
por: Yan, Feihu, et al.
Publicado: (2019)

Can Ebola virus become endemic in the human population?
por: Wong, Gary, et al.
Publicado: (2015)

Potent monoclonal antibody–mediated neutralization of a divergent Hendra virus variant
por: Wang, Zhaoqian, et al.
Publicado: (2022)

Naturally Occurring Single Mutations in Ebola Virus Observably Impact Infectivity
por: Wong, Gary, et al.
Publicado: (2018)

Tolcapone Potently Inhibits Seminal Amyloid Fibrils Formation and Blocks Entry of Ebola Pseudoviruses
por: Qiu, Mengjie, et al.
Publicado: (2020)

Generation and Characterization of Anti-Filovirus Nucleoprotein Monoclonal Antibodies
por: Rahim, Md Niaz, et al.
Publicado: (2019)

A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant
por: Hingankar, Nitin, et al.
Publicado: (2022)

Native Human Monoclonal Antibodies with Potent Cross-Lineage Neutralization of Influenza B Viruses
por: Vigil, Adam, et al.
Publicado: (2018)

Mechanistic basis for potent neutralization of Sin Nombre hantavirus by a human monoclonal antibody
por: Stass, Robert, et al.
Publicado: (2023)

Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants
por: Chen, Zhaochun, et al.
Publicado: (2022)

Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD
por: Ma, Hang, et al.
Publicado: (2022)

A Human Monoclonal Antibody against Hepatitis B Surface Antigen with Potent Neutralizing Activity
por: Cerino, Antonella, et al.
Publicado: (2015)

A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody
por: Nogales, Aitor, et al.
Publicado: (2018)

Potent Neutralization Ability of a Human Monoclonal Antibody Against Serotype 1 Dengue Virus
por: Lu, Jiansheng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vnk1ufheqn7prcljpd3hlr5r3o